Last reviewed · How we verify
Tobacco Dependence
Approved treatments
Pipeline
- 0.5mg Varenicline b.i.d. · Pfizer Inc. — preclinical
- 1.0mg Varenicline b.i.d. · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tobacco Dependence patent landscape — cliff calendar, originator estates, attackable patents
- Tobacco Dependence treatment landscape brief
- Tobacco Dependence treatment updates RSS
Frequently asked questions about Tobacco Dependence
What new drugs are in development for Tobacco Dependence?
2 pipeline drugs tracked. Top candidates: 0.5mg Varenicline b.i.d., 1.0mg Varenicline b.i.d..
Related
- Treatment landscape: Tobacco Dependence patent cliff · Tobacco Dependence CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing